KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Net Cash Flow Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 83.65%
Dec 31, 2025 35.46%
Sep 30, 2025 92.50%
Jun 30, 2025 -20.46%
Mar 31, 2025 -31.40%
Dec 31, 2024 20.60%
Sep 30, 2024 -15.43%
Jun 30, 2024 25.99%
Mar 31, 2024 -37.93%
Dec 31, 2023 -36.56%
Sep 30, 2023 -23.03%
Jun 30, 2023 47.12%
Mar 31, 2023 32.14%
Dec 31, 2022 -34.13%
Sep 30, 2022 63.23%
Jun 30, 2022 -12.69%
Mar 31, 2022 -70.69%
Dec 31, 2021 -74.78%
Sep 30, 2021 44.24%
Jun 30, 2021 31.60%
Mar 31, 2021 34.19%
Dec 31, 2020 -38.37%
Sep 30, 2020 36.66%
Jun 30, 2020 9.39%
Mar 31, 2020 31.31%
Dec 31, 2019 -151.98%
Sep 30, 2019 60.73%
Jun 30, 2019 -36.60%
Mar 31, 2019 40.63%
Dec 31, 2018 -2.28%
Sep 30, 2018 -5.91%
Jun 30, 2018 -34.67%
Mar 31, 2018 59.03%
Dec 31, 2017 18.25%
Sep 30, 2017 74.69%
Jun 30, 2017 -19.57%
Mar 31, 2017 15.36%
Dec 31, 2016 -15.77%
Sep 30, 2016 19.19%
Jun 30, 2016 -15.51%
Mar 31, 2016 9.19%
Dec 31, 2015 22.26%
Sep 30, 2015 -19.72%
Jun 30, 2015 29.77%
Mar 31, 2015 -7.01%
Dec 31, 2014 15.75%
Sep 30, 2014 -25.46%
Jun 30, 2014 28.34%
Mar 31, 2014 -16.19%